The Trp64Arg mutation of the β3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts

Journal of Clinical Investigation

Volumn 98, Issue 9, 1996, Pages 2086-2093

  Gagnon, Jacques ^a   Mauriège, Pascale ^a   Roy, Sonia ^a   Sjöström, David ^b   Chagnon, Yvon C ^a   Dionne, France T ^a   Oppert, Jean Michel ^a   Pérusse, Louis ^a   Sjöström, Lars ^b   Bouchard, Claude ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

body fat; diabetes; linkage; mutation; visceral fat

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; DNA; BETA ADRENERGIC RECEPTOR;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; OBESITY; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE; RISK FACTOR; AMINO ACID SEQUENCE; BASAL METABOLIC RATE; CANADA; CLINICAL TRIAL; GENETIC LINKAGE; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; POINT MUTATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AMINO ACID SEQUENCE; BASAL METABOLISM; BASE SEQUENCE; BODY MASS INDEX; BODY WEIGHT; FEMALE; GENE FREQUENCY; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OBESITY; PEDIGREE; PHENOTYPE; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; QUEBEC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0029658675     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119014     Document Type: Article

References (55)

1. Bouchard, C., and L. Pérusse. 1993. Genetics of obesity. Annu. Rev. Nutr. 13:337-354.
2. Ravussin, E., S. Lillioja, W.C. Knowler, L. Christin, D. Freymond, G.H. Abbott, V. Boyce, B.V. Howard, and C. Bogardus. 1988. Reduced rate of energy expenditure as a risk factor for body weight gain. N. Engl. J. Med. 318:467-472.
3. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34:1057-1091.
4. Arch, J.R.S., and A.J. Kaumann. 1993. β3 and atypical β-adrenoceptors. Med. Res. Rev. 13:663-729.
5. Emorine, L.J., S. Marullo, M.M. Briend-Sutren, G. Patey, K. Tate, C. Delavier-Klutchko, and D. Strosberg. 1989. Molecular characterization of the human β3-adrenergic receptor. Science (Wash. DC). 245:1118-1121.
6. Granneman, J.G., K.N. Lahners, and A. Chaudry. 1993. Characterization of the human β3-adrenergic receptor gene. Mol. Pharmacol. 44:264-270.
7. Lelias, J.M., M. Kaghad, M. Rodriguez, P. Chalon, J. Bonnin, I. Dupré, B. Delpech, M. Bensaid, G. LeFur, P. Ferrara, and D. Caput. 1993. Molecular cloning of a human β3-adrenergic receptor. FEBS Lett. 324:127-130.
8. Pietri-Rouxel, F., G. Lensen, A. Kapoor, M.F. Drumare, P. Archimbault, A.D. Strosberg, and B.S. Manning. 1995. Molecular cloning and pharmacological characterization of the bovine beta 3-adrenergic receptor. Eur. J. Biochem. 230:350-358.
9. Granneman, J.G., K.N. Lahners, and A. Chaudry. 1991. Molecular cloning and expression of the rat β3-adrenergic receptor. Mol. Pharmacol. 40:895-899.
10. Muzzin, P., J.P. Revelli, F. Kuhne, J.D. Gocayne, W.R. McCombie, J.C. Venter, J.P. Giacobino, and C.M. Fraser. 1991. An adipose tissue specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem. 266:24053-24058.
11. Nahmias, C., N. Blin, J.M. Elalouf, M.G. Mattei, A.D. Strosberg, and L.J. Emorine. 1991. Molecular characterization of the mouse β3-adrenergic receptor: relationship with the atypical adrenoceptor of adipocytes. EMBO J. 10: 3721-3727.
12. Zaagsma, J., and S.R. Nahorski. 1990. Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical β3-adrenoceptor? Trends Pharmacol. Sci. 11:3-7.
13. Krief, S., F. Lönnqvist, S. Raimbault, B. Baude, A. Van Spronsen, P. Arner, A.D. Strosberg, D. Ricquier, and L.J. Emorine. 1993. Tissue distribution of β3-adrenergic receptor mRNA in man. J. Clin. Invest. 91:344-349.
14. Emorine, L.J., N. Blin, and A.D. Strosberg. 1994. The human β3-adrenoceptor: the search for a physiological function. Trends Pharmacol. Sci. 15:3-7.
15. Langin, D., M.P. Portillo, J.S. Saulnier-Blache, and M. Lafontan. 1991. Coexistence of three beta-adrenoceptor subtypes in white fat cells from various mammalian species. Eur. J. Pharmacol. 199:291-301.
16. Bousquet-Mélou, A., J. Galitzky, M. Lafontan, and M. Berlan. 1995. Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans. J. Lipid Res. 36:451-461.
17. Tavernier, G., P. Barbe, J. Galitzky, M. Berlan, D. Caput, M. Lafontan, and D. Langin. 1996. Expression of β3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J. Lipid Res. 37:87-97.
18. Rosenbaum, M., C.C. Malbon, J. Hirsch, and R.L. Leibel. 1993. Lack of β3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J. Clin. Endocrinol. Metab. 77:352-355.
19. Lönnqvist, F., S. Krief, A.D. Strosberg, B. Nyberg, L.J. Emorine, and P. Arner. 1993. Evidence of a functional β3-adrenoceptor in man. Br. J. Pharmacol. 110:929-936.
20. Lönnqvist, F., A. Thörne, K. Nilsell, J. Hoffstedt, and P. Arner. 1995. A pathogenic role of visceral fat β3-adrenoceptors in obesity. J. Clin. Invest. 95: 1109-1116.
21. Van Liefde, I., A. Van Ermen, and G. Vauquelin. 1994. No functional atypical β-adrenergic receptors in human omental adipocytes. Life Sci. 54:209-214.
22. Mauriège, P., A. Marette, C. Atgié, C. Bouchard, G. Thériault, L.J. Bukowiecki, P. Marceau, S. Biron, A. Nadeau, and J.P. Després. 1995. Regional variation in adipose tissue metabolism of severely obese women. J. Lipid Res. 36:672-684.
23. Enocksson, S., M. Shimizu, F. Lönnqvist, J. Nordenström, and P. Arner. 1995. Demonstration of an in vivo functional β3-adrenoceptor in man. J. Clin. Invest. 95:2239-2245.
24. Barbe, P., L. Millet, J. Galitzky, M. Lafontan, and M. Berlan. 1996. Insitu assessment of the role of the β1-, β2- and β3-adrenoceptors in the control of lipolysis and nutritive blood-flow in human subcutaneous adipose-tissue. Br. J. Pharmacol. 117:907-913.
25. Hoffstedt, J., M. Shimizu, S. Sjöstedt, and F. Lönnqvist. 1995. Determination of β3-adrenoceptor mediated lipolysis in human fat cells. Obes. Res. 3:447-457.
26. Walston, J., K.D. Silver, C. Bogardus, W.C. Knowler, F.S. Celi, S. Austin, B. Manning, A.D. Strosberg, M.P. Stern, N. Raben et al. 1995. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic receptor gene. N. Engl. J. Med. 333:343-347.
27. Widén, E., M. Lehto, T. Kanninen, J. Walston, A.R. Shuldiner, and L.C. Groop. 1995. Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333:348-351.
28. Clément, K., C. Vaisse, B. St-J Manning, A. Basdevant, B. Guy-Grand, J. Ruiz, K.D. Silver, A.R. Shuldiner, P. Froguel, and A.D. Strosberg. 1995. Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333:352-354.
29. Kadowaki, H., K. Yasuda, K. Iwamoto, S Otabe, K. Shimokawa, K. Silver, J. Walston, H. Yoshinaga, K. Kosaka, N. Yamada et al. 1995. A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem. Biophys. Res. Commun. 215:555-560.
30. Yoshida, T., N. Sakane, T. Umekawa, M. Sakai, T. Takashaki, and M. Kondo. 1995. Mutation of β3-adrenergic-receptor gene and response to treatment of obesity. Lancet. 346:1433-1434.
31. Bouchard, C. 1996. Genetic epidemiology, association, and sib-pair linkage: Results from the Québec Family Study. In Molecular and Genetic Aspects of Obesity. Vol. 5. G.A. Bray and D.H. Ryan, editors. Louisiana State Univer sity Press, Pennington Center Nutrition Series, Baton Rouge, LA. 470-481.
32. Sjöström, L., B. Larsson, L. Backman, C. Bengtsson, C. Bouchard, S. Dahlgren, P. Hallgren, E. Jonsson, J. Karlsson, L. Lapidus et al. 1992. Swedish obese subjects (SOS): Recruitment for an intervention study and a selected description of the obese state. Int. J. Obes. 16:465-479.
33. Lissner, L., L. Sjöström, C. Bengtsson, C. Bouchard, and B. Larsson. 1994. The natural history of obesity in an obese population and associations with metabolic aberrations. Int. J. Obes. 18:441-447.
34. Behnke, A.R., and J.H. Wilmore. 1974. Evaluation and regulation of body build and composition. Prentice Hall, Englewood Cliffs. NJ. 20-37.
35. Meneely, G.R., and N.L. Kaltreider. 1949. The volume of the lung determined by helium dilution: description of the method and comparison with other procedures. J. Clin. Invest. 28:129-139.
36. Siri, W.E. 1956. The gross composition of the body. In Advances in biological and medical physics. Vol 4. J.H. Lawrence, and C.A. Tobias, editors. Academic Press, NY. 239-280.
37. The Airlie (VA) consensus conference. 1988. In Anthropometric Standardization Reference Manual. T.G. Lohman, A.F. Roche, and R. Martorell, editors. Human Kinetics Publishers, Champaign, IL. 39-80.
38. Ferland, M., J.P. Després, A. Tremblay, S. Pinault, A. Nadeau, S. Moorjani, P.J. Lupien, G. Thériault, and C. Bouchard. 1989. Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements. Br. J. Nutr. 61:139-148.
39. Oppert, J.M., M.C. Vohl, M. Chagnon, F.T. Dionne, A.M. Cassard-Doulcier, D. Ricquier, L. Pérusse, and C. Bouchard. 1994. DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. Int. J. Obes. 18:526-531.
40. Weir, J.B. 1949. New methods for calculating metabolic rate with special reference to protein metabolism. J. Physiol. (Lond). 109:1-9.
41. Oppert, J.M., A. Nadeau, A. Tremblay, J-P. Després, G. Thériault, O. Dériaz, and C. Bouchard. 1995. Plasma glucose, insulin and glucagon before and after long term overfeeding in identical twins. Metab. Clin. Exp. 44:96-105.
42. Richterich, R., and H. Dauwalder. 1971. Zur Bestimmung der Plasmaglukose-Konzentration mit der Hexokinase-Glucose-6-Phosphat-Dehydrogenase Methode. Schweiz. Med. Wochenschr. 101:615-618.
43. Desbuquois, B., and G.D. Aurbach. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 37:732-738.
44. Nilsson, K. 1976. Establishment of permanent human lymphoblastoid cell lines in vitro. In In Vitro Methods in Cell-Mediated and Tumor Immunity. B.R. Bloom, and J.R. David , editors. Academic Press, New York. 713-735.
45. Haseman, J.K., and R.C. Elston. 1972. The investigation of linkage between a quantitative trait and a marker locus. Behav. Genet. 2:3-19.
46. Amos, C.I., R.C. Elston, A.F. Wilson, and J.E. Bailey-Wilson. 1989. A more powerful test of linkage for quantitative traits. Genet. Epidemiol. 6:435-439.
47. Statistical Analysis for Genetic Epidemiology, release 2.1 (SAGE). 1992. Computer program package available from the Department of Biometry and Genetics, LSU Medical Center, New Orleans.
48. Benson, D.A., M. Boguski, D.J. Lipman, and J. Ostell. 1994. GenBank. Nucl. Acid Res. 22:3441-3444.
49. Li, L.S., F. Lönnqvist, H. Luthman, and P. Arner. 1996. Phenotypic characterization of the Trp64Arg polymorphism in the beta3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia. 39:857-860.
50. Susulic, V.S., R.C. Frederich, J. Lawitts, E. Tozzo, B.B. Kahn, M.E. Harper, J. Himms-Hagen, J.S. Flier, and B.B. Lowell. 1995 Targeted disruption of the β3-adrenergic receptor gene. J. Biol. Chem. 270:29483-29492.
51. Emorine, L., and D. Strosberg. 1993. Structure et fonction du récepteur β3-adrénergique. Med. Sci. 9:1228-1235.
52. Ezzel, C. 1995. Research in a focus; fat times for obesity research: Tons of new information, but how does it all fit together? J NIH Res. 7:39-43.
53. Mahmoudian, M. 1994. The complex of human Gs protein with the beta3 adrenergic receptor: A computer-aided molecular modeling study. J. Mol. Graphics. 12:22-28.
54. Liggett, S. 1995. Functional properties of human β2-adrenergic receptor polymorphism. NIPS. 10:265-273.
55. Strosberg, A.D. 1995. Adrenergic, dopaminergic and histaminergic drugs: Structure, function, and regulation of the three β-Adrenergic receptors. Obes. Res. 3(suppl.):501S-505S.